Benefits and risks of therapeutic alternatives for macrolide resistant pneumonia in children
Although Mycoplasma pneumoniae pneumonia (MPP) has been generally susceptible to macrolides, the emergence of macrolide-resistant MPP (MRMP) has made its treatment challenging. MRMP rapidly spread after the 2000s, especially in East Asia. MRMP is more common in children and adolescents than in adult...
Main Author: | Hyeon-Jong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pediatric Society
2019-06-01
|
Series: | Korean Journal of Pediatrics |
Subjects: | |
Online Access: | http://kjp.or.kr/upload/pdf/kjp-2018-07367.pdf |
Similar Items
-
Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis
by: Jong Gyun Ahn, et al.
Published: (2021-09-01) -
Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
by: Hye-Kyung Cho
Published: (2021-09-01) -
GROUP B AND G BETA-HEMOLYTIC STREPTOCOCCI IN POMURJE REGION – CHARACTERISTICS OF ANTIMICROBIAL RESISTANT ISOLATES
by: Iztok Štrumbelj, et al.
Published: (2003-05-01) -
Mechanism of resistance acquisition and treatment of macrolide-resistant pneumonia in children
by: Hyeon-Jong Yang, et al.
Published: (2017-06-01) -
Research Note: Characterization of antibiotic resistant phenotypes and linked genes of Escherichia coli and Klebsiella pneumoniae from healthy broiler chickens, Karnataka, India
by: Khyati Bhardwaj, et al.
Published: (2021-06-01)